114 related articles for article (PubMed ID: 20933412)
41. Regulation of stearoyl-CoA desaturase activity by the trans-10,cis-12 isomer of conjugated linoleic acid in HepG2 cells.
Choi Y; Park Y; Pariza MW; Ntambi JM
Biochem Biophys Res Commun; 2001 Jun; 284(3):689-93. PubMed ID: 11396956
[TBL] [Abstract][Full Text] [Related]
42. Novel and potent inhibitors of stearoyl-CoA desaturase-1. Part II: Identification of 4-ethylamino-3-(2-hydroxyethoxy)-N-[5-(3-trifluoromethylbenzyl)thiazol-2-yl]benzamide and its biological evaluation.
Uto Y; Ogata T; Kiyotsuka Y; Miyazawa Y; Ueno Y; Kurata H; Deguchi T; Yamada M; Watanabe N; Takagi T; Wakimoto S; Okuyama R; Konishi M; Kurikawa N; Kono K; Osumi J
Bioorg Med Chem Lett; 2009 Aug; 19(15):4159-66. PubMed ID: 19541482
[TBL] [Abstract][Full Text] [Related]
43. Discovery and pharmacological characterization of SAR707 as novel and selective small molecule inhibitor of stearoyl-CoA desaturase (SCD1).
Voss MD; Zoller G; Matter H; Herling AW; Biemer-Daub G; Pfenninger A; Haag-Diergarten S; Keil S; Kohlmann M; Schmidts HL
Eur J Pharmacol; 2013 May; 707(1-3):140-6. PubMed ID: 23524088
[TBL] [Abstract][Full Text] [Related]
44. Azacycloalkane derivatives as inhibitors of delta-9 stearoyl-coenzyme A desaturase.
Liu G
Expert Opin Ther Pat; 2009 Jun; 19(6):885-91. PubMed ID: 19473107
[TBL] [Abstract][Full Text] [Related]
45. Discovery of thiazolylpyridinone SCD1 inhibitors with preferential liver distribution and reduced mechanism-based adverse effects.
Sun S; Zhang Z; Raina V; Pokrovskaia N; Hou D; Namdari R; Khakh K; Ratkay LG; McLaren DG; Mork M; Fu J; Ferreira S; Hubbard B; Winther MD; Dales N
Bioorg Med Chem Lett; 2014 Jan; 24(2):526-31. PubMed ID: 24370012
[TBL] [Abstract][Full Text] [Related]
46. Conjugated linoleic acid decreases hepatic stearoyl-CoA desaturase mRNA expression.
Lee KN; Pariza MW; Ntambi JM
Biochem Biophys Res Commun; 1998 Jul; 248(3):817-21. PubMed ID: 9704011
[TBL] [Abstract][Full Text] [Related]
47. Hormonal regulation of stearoyl coenzyme-A desaturase 1 activity and gene expression in primary cultures of chicken hepatocytes.
Lefevre P; Diot C; Legrand P; Douaire M
Arch Biochem Biophys; 1999 Aug; 368(2):329-37. PubMed ID: 10441384
[TBL] [Abstract][Full Text] [Related]
48. Recent advances in stearoyl-CoA desaturase 1 inhibitors for dyslipidemia and obesity.
Liu G
Curr Top Med Chem; 2010; 10(4):419-33. PubMed ID: 20180759
[TBL] [Abstract][Full Text] [Related]
49. Discovery of Cytochrome P450 4F11 Activated Inhibitors of Stearoyl Coenzyme A Desaturase.
Winterton SE; Capota E; Wang X; Chen H; Mallipeddi PL; Williams NS; Posner BA; Nijhawan D; Ready JM
J Med Chem; 2018 Jun; 61(12):5199-5221. PubMed ID: 29869888
[TBL] [Abstract][Full Text] [Related]
50. Novel benzoylpiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 6-[4-(2-methylbenzoyl)piperidin-1-yl]pyridazine-3-carboxylic acid (2-hydroxy-2-pyridin-3-ylethyl)amide and its plasma triglyceride-lowering effects in Zucker fatty rats.
Uto Y; Ogata T; Kiyotsuka Y; Ueno Y; Miyazawa Y; Kurata H; Deguchi T; Watanabe N; Konishi M; Okuyama R; Kurikawa N; Takagi T; Wakimoto S; Ohsumi J
Bioorg Med Chem Lett; 2010 Jan; 20(1):341-5. PubMed ID: 19926281
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of Stearoyl-CoA Desaturase 1 expression in human lung adenocarcinoma cells impairs tumorigenesis.
Scaglia N; Igal RA
Int J Oncol; 2008 Oct; 33(4):839-50. PubMed ID: 18813799
[TBL] [Abstract][Full Text] [Related]
52. A novel assay of cellular stearoyl-CoA desaturase activity of primary rat hepatocytes by HPLC.
Su C; Gullberg H; Simko H; Luthman M; Edlund PO; Lundbäck T
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Sep; 878(26):2427-32. PubMed ID: 20732836
[TBL] [Abstract][Full Text] [Related]
53. Novel spiropiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 1'-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-5-(trifluoromethyl)-3,4-dihydrospiro[chromene-2,4'-piperidine].
Uto Y; Kiyotsuka Y; Ueno Y; Miyazawa Y; Kurata H; Ogata T; Deguchi T; Yamada M; Watanabe N; Konishi M; Kurikawa N; Takagi T; Wakimoto S; Kono K; Ohsumi J
Bioorg Med Chem Lett; 2010 Jan; 20(2):746-54. PubMed ID: 20006498
[TBL] [Abstract][Full Text] [Related]
54. Obesity resistance of the stearoyl-CoA desaturase-deficient (scd1-/-) mouse results from disruption of the epidermal lipid barrier and adaptive thermoregulation.
Binczek E; Jenke B; Holz B; Günter RH; Thevis M; Stoffel W
Biol Chem; 2007 Apr; 388(4):405-18. PubMed ID: 17391062
[TBL] [Abstract][Full Text] [Related]
55. Systematic evaluation of amide bioisosteres leading to the discovery of novel and potent thiazolylimidazolidinone inhibitors of SCD1 for the treatment of metabolic diseases.
Sun S; Zhang Z; Kodumuru V; Pokrovskaia N; Fonarev J; Jia Q; Leung PY; Tran J; Ratkay LG; McLaren DG; Radomski C; Chowdhury S; Fu J; Hubbard B; Winther MD; Dales NA
Bioorg Med Chem Lett; 2014 Jan; 24(2):520-5. PubMed ID: 24374272
[TBL] [Abstract][Full Text] [Related]
56. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c.
Biddinger SB; Miyazaki M; Boucher J; Ntambi JM; Kahn CR
Diabetes; 2006 Jul; 55(7):2032-41. PubMed ID: 16804073
[TBL] [Abstract][Full Text] [Related]
57. Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery.
Brown JM; Rudel LL
Curr Opin Lipidol; 2010 Jun; 21(3):192-7. PubMed ID: 20216310
[TBL] [Abstract][Full Text] [Related]
58. Fructose-1,6-bisphosphatase Inhibitors. 2. Design, synthesis, and structure-activity relationship of a series of phosphonic acid containing benzimidazoles that function as 5'-adenosinemonophosphate (AMP) mimics.
Dang Q; Kasibhatla SR; Xiao W; Liu Y; Dare J; Taplin F; Reddy KR; Scarlato GR; Gibson T; van Poelje PD; Potter SC; Erion MD
J Med Chem; 2010 Jan; 53(1):441-51. PubMed ID: 20055427
[TBL] [Abstract][Full Text] [Related]
59. Scd3--a novel gene of the stearoyl-CoA desaturase family with restricted expression in skin.
Zheng Y; Prouty SM; Harmon A; Sundberg JP; Stenn KS; Parimoo S
Genomics; 2001 Jan; 71(2):182-91. PubMed ID: 11161812
[TBL] [Abstract][Full Text] [Related]
60. Tumor-Activated Benzothiazole Inhibitors of Stearoyl-CoA Desaturase.
Williams NS; Gonzales S; Naidoo J; Rivera-Cancel G; Voruganti S; Mallipeddi P; Theodoropoulos PC; Geboers S; Chen H; Ortiz F; Posner B; Nijhawan D; Ready JM
J Med Chem; 2020 Sep; 63(17):9773-9786. PubMed ID: 32787093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
